Fed. Circ. Bars Pfizer Appeal Over Roche Antibody Drug IP
The Federal Circuit on Monday threw out Pfizer's appeal of a Patent Trial and Appeal Board ruling that upheld the validity of a Hoffman-La Roche Ltd. unit's patents for purifying antibodies...To view the full article, register now.
Already a subscriber? Click here to view full article